|
Retinal Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
In 5 eyes (8.6%), differences were revealed between conventional FAF and UWF-FAF in detecting retinopathy.
|
31526798 |
2020 |
|
Acute myocardial infarction
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
One novel lncRNA FGF9-associated factor (termed FAF) and mRNAs in AMI rats were verified by bioinformatics, real-time polymerase chain reaction or western blot.
|
31093967 |
2019 |
|
Multiple evanescent white dot syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
NIR-FAF and SD-OCT should be considered as non-invasive investigations in the detection of MEWDS-related foveal granularity.
|
28981397 |
2019 |
|
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Low-CNA SCCs tended to be HPV(+) and display hypermethylation with repression of TET1 demethylase and FANCF, previously linked to predisposition to SCC, or harbor mutations affecting CASP8, RAS-MAPK pathways, chromatin modifiers, and immunoregulatory molecules.
|
29617660 |
2018 |
|
Pure Red-Cell Aplasia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
FANCF and LRP1B mutations may be associated with acquired PRCA.
|
29767669 |
2018 |
|
Stargardt's disease
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Peripheral FAF changes may have implications for diagnosis, prognosis, and management of individual patients with Stargardt disease.
|
28248825 |
2018 |
|
HER2-positive carcinoma of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
This manuscript explores the intracellular fate of FAF in MDA-MB-468, a triple negative (ER-/PR-/HER2-) breast cancer line.
|
30386244 |
2018 |
|
HER2-negative breast cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
This manuscript explores the intracellular fate of FAF in MDA-MB-468, a triple negative (ER-/PR-/HER2-) breast cancer line.
|
30386244 |
2018 |
|
Epiretinal Membrane
|
0.010 |
Biomarker
|
disease |
BEFREE |
Corresponding B-FAF images, vitreo-macular relations, and type of epiretinal membranes (ERMs) were also examined.
|
28405744 |
2017 |
|
Retinal Dystrophies
|
0.010 |
Biomarker
|
group |
BEFREE |
The purpose of this study was to examine possible genotypic/phenotypic correlations of UW-FAF patterns in patients with a variety of retinal dystrophies and retinitis pigmentosa (RP).
|
27880076 |
2017 |
|
STARGARDT DISEASE 1 (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
UWF-FAF images may provide information for estimating peripheral and central visual function in STGD.
|
29038010 |
2017 |
|
Reticular pseudodrusen
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The most sensitive image modality for RPD was IR (93%), followed by FAF (92%), OCT (74%, RF (33%) and CFP (29%).
|
27768118 |
2017 |
|
Epithelial ovarian cancer
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
CpG island methylation of FANCF gene promoter region is strongly associated with the susceptibility and clinicopathologic features of EOC.
|
26507869 |
2016 |
|
Secondary malignant neoplasm of lymph node
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
The FANCF promoter methylation rates showed significant differences in the comparisons stratified by age, International Federation of Gynecology and Obstetrics (FIGO) staging, histopathological classification, and lymph node metastasis (all P < .05).
|
26507869 |
2016 |
|
Congenital Abnormality
|
0.010 |
GeneticVariation
|
group |
BEFREE |
A careful examination of three electively aborted fetuses in one family and one affected girl in the other indicated an association of the FANCF loss-of-function mutation with a severe phenotype characterized by multiple malformations.
|
26033879 |
2015 |
|
Childhood Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Involvement of Fanconi anemia genes FANCD2 and FANCF in the molecular basis of drug resistance in leukemia.
|
25647473 |
2015 |
|
Invasive carcinoma of breast
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
FANCF methylation is a rare event in Japanese primary invasive breast cancer.
|
19813073 |
2011 |
|
Triple Negative Breast Neoplasms
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
No significant correlation was found between FANCF methylation and the expression of ER, PR, HER2, and TNBC.
|
19813073 |
2011 |
|
Triple-Negative Breast Carcinoma
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
No significant correlation was found between FANCF methylation and the expression of ER, PR, HER2, and TNBC.
|
19813073 |
2011 |
|
Bloom Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
MM1 interacts with the FA core complex by binding to FANCF, whereas MM2 interacts with RM1 and topoisomerase IIIalpha, components of the BS complex.
|
20064461 |
2009 |
|
Mammary Neoplasms
|
0.010 |
PosttranslationalModification
|
group |
LHGDN |
In contrast, FANCF methylation was rare in breast tumors: one of 120 (0.8%).
|
17932744 |
2008 |
|
Mammary Neoplasms
|
0.010 |
PosttranslationalModification
|
group |
BEFREE |
In contrast, FANCF methylation was rare in breast tumors: one of 120 (0.8%).
|
17932744 |
2008 |
|
Malignant neoplasm of urinary bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
These low proportions suggest that in contrast to other types of tumors silencing of FANCF is a rare event in bladder cancer and that an intact FA/BRCA pathway might be advantageous for tumor progression.
|
18000367 |
2007 |
|
Bladder Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
These low proportions suggest that in contrast to other types of tumors silencing of FANCF is a rare event in bladder cancer and that an intact FA/BRCA pathway might be advantageous for tumor progression.
|
18000367 |
2007 |
|
Carcinoma of bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
These low proportions suggest that in contrast to other types of tumors silencing of FANCF is a rare event in bladder cancer and that an intact FA/BRCA pathway might be advantageous for tumor progression.
|
18000367 |
2007 |